UniProtKB/Swiss-Prot Q06418: Variant p.Arg824Gly

Tyrosine-protein kinase receptor TYRO3
Gene: TYRO3
Feedback?

Variant information Variant position:

824 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Glycine (G) at position 824 (R824G, p.Arg824Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs17857364 [ dbSNP | Ensembl ]

Sequence information Variant position:

824 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

890 The length of the canonical sequence.
Location on the sequence:

YINIERAEEPTAGGSLELPG R DQPYSGAGDGSGMGAVGGTP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         YINIERA--EEPTAGGSLELPGRDQPY-SGAGDGSGM------------GAVGGTP

Mouse                         YINIERA--EQPTESGSPEVHCGERSS-SEAGDGSGV----

Rat                           YINIERA--GQPAENGSPELPCGEQSS-SEAGDGSGM----

Chicken                       YVNIGKD--KESSVS-DPAVHTSFGNT-DGDETIAG-----

Xenopus laevis                YVNLGETCGAAAAVSGLHSAFCSEEDYCAGPSQTCG-----

Xenopus tropicalis            YVNLGETCGAAAAVSGLHSAFCKEEDYCAGPSQTCG-----

Zebrafish                     YVNLEEEDGEQANSG----TRSSEEPSWGVPWQCAGIEEDE

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	41 – 890	Tyrosine-protein kinase receptor TYRO3
Topological domain	451 – 890	Cytoplasmic
Region	815 – 837	Disordered
Modified residue	804 – 804	Phosphotyrosine; by autocatalysis
Modified residue	818 – 818	Phosphoserine

Literature citations
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANTS LEU-21; SER-542; MET-819 AND GLY-824;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.